Stockton, SD. and Jr, Devi, LA. (2012) Functional relevance of μ-δ opioid receptor heteromerization: A Role in novel signaling and implications for the treatment of addiction disorders: From a symposium on new concepts in mu-opioid pharmacology. Drug and Alcohol Dependence Mar 1;121(3):167-72. doi: 10.1016/j.drugalcdep.2011.10.025. Epub 2011 Nov 23
Traynor, J. (2012) μ-Opioid receptors and regulators of G protein signaling (RGS) proteins: From a symposium on new concepts in mu-opioid pharmacology. Drug and Alcohol Dependence Mar 1;121(3):173-80. doi: 10.1016/j.drugalcdep.2011.10.027. Epub 2011 Nov 29
Lamb, K., Tidgewell, K., Simpson, DS., Bohn, LM. and Prisinzano, TE. (2012) Antinociceptive effects of herkinorin, a MOP receptor agonist derived from salvinorin A in the formalin test in rats: New concepts in mu opioid receptor pharmacology: From a symposium on new concepts in mu-opioid pharmacology. Drug and Alcohol Dependence Mar 1;121(3):181-8. doi: 10.1016/j.drugalcdep.2011.10.026. Epub 2011 Nov 26
Whistler, JL. (2012) Examining the role of mu opioid receptor endocytosis in the beneficial and side-effects of prolonged opioid use: From a symposium on new concepts in mu-opioid pharmacology. Drug and Alcohol Dependence Mar 1;121(3):189-204. doi: 10.1016/j.drugalcdep.2011.10.031. Epub 2012 Jan 9
Zorrilla, EP., Heilig, M., de Wit, H. and Shaham, Y. (2013) Behavioral, biological, and chemical perspectives on targeting CRF1 receptor antagonists to treat alcoholism. Drug and Alcohol Dependence Mar 1;128(3):175-86. doi: 10.1016/j.drugalcdep.2012.12.017. Epub 2013 Jan 5
De Biasi, M., McLaughlin, I., Perez, EE., Crooks, PA., Dwoskin, LP., Bardo, MT., Pentel, PR. and Hatsukami, D. (2014) Scientific overview: 2013 BBC plenary symposium on tobacco addiction. Drug and Alcohol Dependence Aug 1;141:107-17. doi: 10.1016/j.drugalcdep.2014.05.013. Epub 2014 Jun 2. Erratum in: Drug Alcohol Depend. 2014 Nov 1;144:290
Reith, ME., Blough, BE., Hong, WC., Jones, KT., Schmitt, KC., Baumann, MH., Partilla, JS., Rothman, RB. and Katz, JL. (2015) Behavioral, biological and chemical perspectives on atypical agents targeting the dopamine transporter. Drug and Alcohol Dependence Feb 1;147C:1-19. doi: 10.1016/j.drugalcdep.2014.12.005. Epub 2014 Dec 18
Funding for this conference is made possible [in part] by R13 DA029347 from The National Institute on Drug Abuse (NIDA). The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.